Gene array studies have identified high expression of the transcription factor upstream stimulatory factor 2 (USF2) in CML patients, and USF2 has been proposed as a miR-10a target through computational algorithms [36]. Here, USF2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.